Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | 2-Chloroethyl chloroformate | HCID 12305 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Aripiprazole | HCID 60795 | — |
| Solvent | 2-Methyltetrahydrofuran | HCID 7301 | — |
| Product | HCID 66810209 | HCID 66810209 | — |
Reaction Steps
To a suspension of aripiprazole (2.0 g, 4.46 mmol) in 2-methyltetrahydrofuran (50 mL) was added NaH (357 mg, 8.92 mmol). The reaction was stirred overnight at room temperature then chloroethyl chloroformate (1.46 mL, 13.38 mmol) was added. Further 2-methyltetrahydrofuran (10 mL) was added to aid stirring. The reaction was stirred overnight at room temperature. The reaction was cooled to 0° C., diluted with ethyl acetate (50 mL) and quenched with aqueous saturated NaHCO3 (50 mL). The reaction was extracted with ethyl acetate (3×50 mL). The combined organics were dried (MgSO4) and concentrated to give 1-chloroethyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate (crude yield 2.22 g) as a 3:2 mixture of aripiprazole/product. The product was taken onto the next step without purification.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08592427B2 |
|---|
| Source dataset | uspto-grants-2013_11 |
|---|
| ORD ID | ord-05421fd9318847e4a1cd2c59c46108a7 |
|---|
| Source note | uspto-grants-2013_11 |
|---|